Clinical trials
Phase 1/2 Gliosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 11 |
| 2001 | 3 |
| 2002 | 6 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2020 | 2 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 59 |
| Terminated | 8 |
| Unknown status | 5 |
| Withdrawn | 3 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 21 |
| New Approaches to Brain Tumor Therapy Consortium | 7 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 7 |
| M.D. Anderson Cancer Center | 6 |
| Alliance for Clinical Trials in Oncology | 3 |
| Duke University | 3 |
| Radiation Therapy Oncology Group | 3 |
| Jonsson Comprehensive Cancer Center | 2 |
| Northwestern University | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gliosarcoma | 80 |
| Glioblastoma | 78 |
| Brain Neoplasms | 50 |
| Central Nervous System Neoplasms | 40 |
| Astrocytoma | 37 |
| Oligodendroglioma | 27 |
| Glioma | 23 |
| Ependymoma | 5 |
| Medulloblastoma | 4 |
| Meningioma | 4 |
Trials
Showing 76 to 80 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.